Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Summary
The purpose of this study is to determine the long-term safety of the study intervention orforglipron as a monotherapy or in combination with oral antihyperglycemic medication. This study includes 3 periods as follows: * screening and lead-in period: up to 4 weeks * treatment period: 52 weeks, including 20 weeks of dose escalation, and * safety follow-up period: 2 weeks.
Official title: A Phase 3, Long-term Safety Study of LY3502970 in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone or in Combination With Oral Antihyperglycemic Medications (ACHIEVE-J)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
401
Start Date
2023-09-28
Completion Date
2025-06-05
Last Updated
2026-06-30
Healthy Volunteers
No
Conditions
Interventions
Orforglipron
Administered orally
Locations (40)
Nakayama Clinic
Nagoya, Aichi-ken, Japan
Shinkashiwa Clinic
Kashiwa, Chiba, Japan
Kashiwa City Hospital
Kashiwa, Chiba, Japan
Tokuyama Clinic
Mihama-ku,Chiba City, Chiba, Japan
Mikannohana Clinic, Diabetes, Endocrinology and Metabolism
Matsuyama, Ehime, Japan
Steel Memorial Yawata Hospital
Kitakyushu, Fukuoka, Japan
Hasegawa Medical Clinic
Chitose, Hokkaido, Japan
Odori Diabetes
Sapporo, Hokkaido, Japan
Matsuda Clinic
Kobe, Hyōgo, Japan
Nakamoto Internal Medicine Clinic
Mito, Ibaraki, Japan
MinamiAkatsukaClinic
Mito, Ibaraki, Japan
Nakakinen clinic
Naka, Ibaraki, Japan
Nishiyamadou Keiwa Hospital
Naka, Ibaraki, Japan
Taya Clinic Koueikai Medical Corporation
Tsuchiura, Ibaraki, Japan
Shonan Takai Clinic
Kamakura, Kanagawa, Japan
Takai Internal Medicine Clinic
Kamakura-shi, Kanagawa, Japan
Medical Corporation Yuga Tsuruma Kaneshiro Diabetes Clinic
Yamato-shi, Kanagawa, Japan
Yokohama Minoru Clinic
Yokohama, Kanagawa, Japan
Yokkaichi Diabetes Clinic
Yokkaichi, Mie-ken, Japan
Gibo Hepatology Clinic
Matsumoto, Nagano, Japan
Shiraiwa Medical Clinic
Kashihara, Osaka, Japan
Kitada Clinic
Osaka, Osaka, Japan
Medical Corporation Heishinkai OCROM Clinic
Suita-shi, Osaka, Japan
OHAMA Diabetes Clinic
Kawaguchi, Saitama, Japan
Sugiura Internal Medicine Clinic
Sōka, Saitama, Japan
Seiwa Clinic
Adachi-ku, Tokyo, Japan
The Institute for Adult Disease, Asahi Life Foundation
Chuo-ku, Tokyo, Japan
Tokyo-Eki Center-building Clinic
Chuo-ku, Tokyo, Japan
Fukuwa Clinic
Chuo-ku, Tokyo, Japan
Hachioji Diabetes Clinic
Hachioji-shi, Tokyo, Japan
Kanno Naika
Mitaka, Tokyo, Japan
Heishinkai Medical Group ToCROM Clinic
Shinjuku-ku, Tokyo, Japan
Medical Corporation Tao Internal Medicine Clinic
Ube, Yamaguchi, Japan
Fujii Clinic
Ube, Yamaguchi, Japan
Tashiro Endocrinology Clinic
Fukuoka, Japan
Morinaga Ueno Clinic
Kumamoto, Japan
Jinnouchi Hospital
Kumamoto, Japan
Heiwadai Hospital
Miyazaki, Japan
Kansai Electric Power Hospital
Osaka, Japan
Abe Clinic
Ōita, Japan